Introduction/Background Anti-VEGF Dosing Regiments: Review of the Pertinent Studies Comparing the Anti-VEGF Dosing Strategies Conclusions References While ...

This article evaluates the currently used treatment regimens in ocular anti-VEGF therapy for exudative age-related macular degeneration. Anti-VEGF therapies using variable injection regimens and ...

Macular degeneration can lead to loss of central vision. You may see dark spots, crooked lines, or blurriness in the center of your eye, but still have good peripheral vision. While the later ...

Fast-growing turkeys put on weight so quickly that their carcasses can develop stripes of fat where muscle should be. This meat is also more likely to be "pale, soft, and exudative", aka slimy, ...

Non-exudative: It is the most common. It is caused by virus and does not produce fluids like pus.

Ixoberogene soroparvovec is a gene therapy commercialized by Adverum Biotechnologies, with a leading Phase II program in Wet (Neovascular / Exudative) Macular Degeneration.

Axitinib is a small molecule commercialized by Ocular Therapeutix, with a leading Phase III program in Wet (Neovascular / Exudative) Macular Degeneration.